Virios Therapeutics enters $6.7M at-the-market equity offering with JonesTrading

Dogwood Therapeutics, Inc.

Agreement allows sale of up to $6.7M of common stock via ATM offering under Rule 415.
Agent JonesTrading receives 3% commission on gross sales; no obligation to sell shares.
Offered under existing shelf registration statement S-3 (No. 333-263700), effective since April 2022.
Agreement effective July 14, 2023; may be terminated by either party at any time.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Dogwood Therapeutics, Inc. entered into Capital On DemandTM Sales Agreement with JonesTrading Institutional Services LLC valued at up to $6.7 million (effective 2023-07-14).

Action: entry
Agreement: atm program
Counterparty: JonesTrading Institutional Services LLC
Value: up to $6.7 million
Effective: 2023-07-14

Exact text from the filing

On July 14, 2023, Virios Therapeutics, Inc. (the “Company”) entered into a Capital On DemandTM Sales Agreement (the “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $6.7 million (the “Shares”).

View on SEC.gov

Browse all material agreements →

Dogwood Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-011892

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.